PT Siloam International Hospitals (SILO) Q1 2026 earnings summary

Executive summary

• Revenue for Q1 2026 reached Rp3,277,776 million, up 7.9% year-over-year from Rp3,036,971 million in Q1 2025, driven by both inpatient and outpatient growth.

• Net profit for Q1 2026 was Rp293,572 million, a 14.8% increase compared to Rp255,803 million in Q1 2025.

• Gross profit margin improved to 38.2% in Q1 2026 from 36.9% in Q1 2025.

• Operating cash flow for Q1 2026 was Rp516,727 million, up from Rp400,444 million in Q1 2025.

Financial highlights

• Operating income for Q1 2026 was Rp412,819 million, up 10.5% year-over-year.

• EBITDA margin increased, supported by higher revenue and controlled operating expenses.

• Earnings per share (EPS) for Q1 2026 was Rp21.56, up from Rp18.95 in Q1 2025.

• Total assets as of March 31, 2026 were Rp15,324,866 million, up from Rp14,498,064 million at December 31, 2025.

• Total equity increased to Rp10,224,356 million as of March 31, 2026.

Outlook and guidance

• Management continues to focus on expanding hospital capacity and improving operational efficiency.

• Ongoing investments in new hospital projects and medical equipment are expected to support future growth.